Active Biotech AB (publ) (NASDAQ Stockholm: ACTI) is a biotechnology company that deploys its extensive knowledge base and portfolio of compounds to develop first-in-class immunomodulatory treatments for specialist oncology and immunology indications with a high unmet medical need and significant commercial potential. Following a portfolio refocus, the business model of Active Biotech aims to advance projects to the clinical development phase and then further develop the programs internally or pursue in partnership. Active Biotech currently holds three projects in its portfolio: The wholly owned small molecule immunomodulators, tasquinimod and laquinimod, both having a mode of actions that includes modulation of myeloid immune cell function, are targeted towards hematological malignancies and inflammatory eye disorders, respectively. Tasquinimod, is in clinical phase Ib/IIa for treatment of multiple myeloma. Laquinimod is in a clinical phase I study with a topical ophthalmic formulation, to be followed by phase II for treatment of non-infectious uveitis. Naptumomab, a targeted anti-cancer immunotherapy, partnered to NeoTX Therapeutics, is in a phase Ib/II clinical program in patients with advanced solid tumors. Please visit www.activebiotech.com for more information.
View Top Employees from Active Biotech AB| Website | http://www.activebiotech.com |
| Ticker | BTPC |
| Revenue | $2 million |
| Employees | 26 (26 on RocketReach) |
| Founded | 1998 |
| Address | 22 Scheelevagen, Lund, Skane 220 07, SE |
| Phone | (464) 619-2000 |
| Fax | (464) 619-1105 |
| Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Pharmaceuticals, Business Services, Science and Engineering |
| Web Rank | 6 Million |
| Keywords | Active Biotech, Active Biotech Investor Relations, Bio Engineering Companies, Active Biotech Ab, Active Biotek |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies |
Looking for a particular Active Biotech AB employee's phone or email?
Active Biotech AB Questions
The Active Biotech AB annual revenue was $2 million in 2024.
Axel Glasmacher is the Board Member of Active Biotech AB.
26 people are employed at Active Biotech AB.
Active Biotech AB is based in Lund, Skane.
The NAICS codes for Active Biotech AB are [541, 54, 54171, 5417, 541713].
The SIC codes for Active Biotech AB are [87, 873].
Top Active Biotech AB Employees
-
1
-
1
-
11
-
11
-
ViewMarie Torngren
Vice President Research and Development at Active Biotech AB
Lund, Skåne, Sweden1
Related Companies
